UCCB01-125, a dimeric inhibitor of PSD-95, reduces inflammatory pain without disrupting cognitive or motor performance: Comparison with the NMDA receptor antagonist MK-801

J. T. Andreasen,A. Bach,Mikko Gynther,A. Nasser,J. Mogensen,K. Strømgaard,D. Pickering
DOI: https://doi.org/10.1016/j.neuropharm.2012.11.006
IF: 5.273
2013-04-01
Neuropharmacology
Abstract:
What problem does this paper attempt to address?